Vafseo ® (vadadustat) was approved by the U.S. Food and Drug Administration in March 2024 for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at ...

About the Phase 2 IGNITE Clinical Trial and ILLUMINATE Natural History Study ...

Akeega – which combines the active ingredients in J&J's PARP inhibitor Zejula (niraparib) and androgen blocker Zytiga ...

The European Commission (EC) has approved Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) plus the ...

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SM ...

A Texas bill, awaiting Governor Abbott's signature, mandates warning labels on foods with ingredients not approved for ...

Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...

We previously reported on an uptick in the passage of state drug price transparency legislation. What follows is an update to that report. As of ...

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

Bealmear accepted a four-month suspension, but he argues that the substance in question neither contained a banned substance, ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a ...